tiprankstipranks
Engene Holdings Inc. (ENGN)
NASDAQ:ENGN
US Market
Want to see ENGN full AI Analyst Report?

enGene Holdings (ENGN) Stock Forecast & Price Target

307 Followers
See the Price Targets and Ratings of:

ENGN Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
3 Buy
8 Hold
0 Sell
Based on 11 analysts giving stock ratings to
enGene
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ENGN Stock 12 Month Forecast

Average Price Target

$6.86
▼(-15.03% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for enGene Holdings in the last 3 months. The average price target is $6.86 with a high forecast of $28.00 and a low forecast of $2.00. The average price target represents a -15.03% change from the last price of $8.07.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","8":"$8","15":"$15","22":"$22","29":"$29"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.857142857142858,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,8,15,22,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.25,8.846153846153847,10.442307692307693,12.038461538461538,13.634615384615385,15.230769230769232,16.826923076923077,18.423076923076923,20.01923076923077,21.615384615384617,23.211538461538463,24.80769230769231,26.403846153846153,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.25,7.21978021978022,7.18956043956044,7.15934065934066,7.1291208791208796,7.098901098901099,7.068681318681319,7.038461538461538,7.008241758241758,6.978021978021978,6.947802197802198,6.917582417582418,6.887362637362638,{"y":6.857142857142858,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.25,6.846153846153846,6.4423076923076925,6.038461538461538,5.634615384615385,5.230769230769231,4.826923076923077,4.423076923076923,4.019230769230769,3.6153846153846154,3.2115384615384617,2.8076923076923075,2.4038461538461533,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.74,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.62,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.83,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.91,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.03,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.76,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.25,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$28.00Average Price Target$6.86Lowest Price Target$2.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$9$2
Hold
-75.22%
Downside
Reiterated
05/14/26
enGene price target lowered to $2 from $9 at UBSenGene price target lowered to $2 from $9 at UBS
H.C. Wainwright Analyst forecast on ENGN
H.C. Wainwright
H.C. Wainwright
$25$6
Buy
-25.65%
Downside
Reiterated
05/08/26
enGene Holdings (ENGN) Gets a Buy from H.C. Wainwright
Piper Sandler Analyst forecast on ENGN
Piper Sandler
Piper Sandler
$7$4
Hold
-50.43%
Downside
Downgraded
05/08/26
enGene downgraded to Neutral from Overweight at Piper SandlerenGene downgraded to Neutral from Overweight at Piper Sandler
Citizens JMP Analyst forecast on ENGN
Citizens JMP
Citizens JMP
Hold
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at CitizensenGene downgraded to Market Perform from Outperform at Citizens
Oppenheimer Analyst forecast on ENGN
Oppenheimer
Oppenheimer
$30
Hold
Reiterated
05/08/26
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
Raymond James Analyst forecast on ENGN
Raymond James
Raymond James
$27$4
Buy
-50.43%
Downside
Reiterated
05/08/26
enGene downgraded to Outperform from Strong Buy at Raymond JamesenGene downgraded to Outperform from Strong Buy at Raymond James
Leerink Partners Analyst forecast on ENGN
Leerink Partners
Leerink Partners
$2
Hold
-75.22%
Downside
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at LeerinkenGene downgraded to Market Perform from Outperform at Leerink
Guggenheim Analyst forecast on ENGN
Guggenheim
Guggenheim
Hold
Downgraded
05/07/26
enGene downgraded to Neutral from Buy at GuggenheimenGene downgraded to Neutral from Buy at Guggenheim
Wells Fargo Analyst forecast on ENGN
Wells Fargo
Wells Fargo
$25$2
Hold
-75.22%
Downside
Downgraded
05/07/26
enGene downgraded to Equal Weight from Overweight at Wells FargoenGene downgraded to Equal Weight from Overweight at Wells Fargo
Morgan Stanley Analyst forecast on ENGN
Morgan Stanley
Morgan Stanley
Hold
Downgraded
05/07/26
enGene downgraded to Equal Weight from Overweight at Morgan StanleyenGene downgraded to Equal Weight from Overweight at Morgan Stanley
Jefferies
$28
Buy
246.96%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on enGene Holdings (ENGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$9$2
Hold
-75.22%
Downside
Reiterated
05/14/26
enGene price target lowered to $2 from $9 at UBSenGene price target lowered to $2 from $9 at UBS
H.C. Wainwright Analyst forecast on ENGN
H.C. Wainwright
H.C. Wainwright
$25$6
Buy
-25.65%
Downside
Reiterated
05/08/26
enGene Holdings (ENGN) Gets a Buy from H.C. Wainwright
Piper Sandler Analyst forecast on ENGN
Piper Sandler
Piper Sandler
$7$4
Hold
-50.43%
Downside
Downgraded
05/08/26
enGene downgraded to Neutral from Overweight at Piper SandlerenGene downgraded to Neutral from Overweight at Piper Sandler
Citizens JMP Analyst forecast on ENGN
Citizens JMP
Citizens JMP
Hold
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at CitizensenGene downgraded to Market Perform from Outperform at Citizens
Oppenheimer Analyst forecast on ENGN
Oppenheimer
Oppenheimer
$30
Hold
Reiterated
05/08/26
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
Raymond James Analyst forecast on ENGN
Raymond James
Raymond James
$27$4
Buy
-50.43%
Downside
Reiterated
05/08/26
enGene downgraded to Outperform from Strong Buy at Raymond JamesenGene downgraded to Outperform from Strong Buy at Raymond James
Leerink Partners Analyst forecast on ENGN
Leerink Partners
Leerink Partners
$2
Hold
-75.22%
Downside
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at LeerinkenGene downgraded to Market Perform from Outperform at Leerink
Guggenheim Analyst forecast on ENGN
Guggenheim
Guggenheim
Hold
Downgraded
05/07/26
enGene downgraded to Neutral from Buy at GuggenheimenGene downgraded to Neutral from Buy at Guggenheim
Wells Fargo Analyst forecast on ENGN
Wells Fargo
Wells Fargo
$25$2
Hold
-75.22%
Downside
Downgraded
05/07/26
enGene downgraded to Equal Weight from Overweight at Wells FargoenGene downgraded to Equal Weight from Overweight at Wells Fargo
Morgan Stanley Analyst forecast on ENGN
Morgan Stanley
Morgan Stanley
Hold
Downgraded
05/07/26
enGene downgraded to Equal Weight from Overweight at Morgan StanleyenGene downgraded to Equal Weight from Overweight at Morgan Stanley
Jefferies
$28
Buy
246.96%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on enGene Holdings (ENGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering enGene Holdings

3 Months
Andres Y. MaldonadoH.C. Wainwright
Success Rate
5/9 ratings generated profit
56%
Average Return
-0.59%
Copying Andres Y. Maldonado's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of -0.59% per trade.
1 Year
Andres Y. MaldonadoH.C. Wainwright
Success Rate
3/9 ratings generated profit
33%
Average Return
-34.22%
Copying Andres Y. Maldonado's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -34.22% per trade.
2 Years
Andres Y. MaldonadoH.C. Wainwright
Success Rate
1/9 ratings generated profit
11%
Average Return
-58.94%
Copying Andres Y. Maldonado's trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -58.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENGN Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
16
10
7
8
10
Buy
0
0
1
1
1
Hold
1
0
1
1
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
10
9
10
22
In the current month, ENGN has received 11 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. ENGN average Analyst price target in the past 3 months is 6.86.
Each month's total comprises the sum of three months' worth of ratings.

ENGN Financial Forecast

ENGN Earnings Forecast

Next quarter’s earnings estimate for ENGN is -$0.47 with a range of -$0.51 to -$0.42. The previous quarter’s EPS was -$0.44. ENGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ENGN is -$0.47 with a range of -$0.51 to -$0.42. The previous quarter’s EPS was -$0.44. ENGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
No data currently available

ENGN Sales Forecast

Next quarter’s sales forecast for ENGN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
Next quarter’s sales forecast for ENGN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.

ENGN Stock Forecast FAQ

What is ENGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Engene Holdings Inc.’s 12-month average price target is 6.86.
    What is ENGN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ENGN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ENGN a Buy, Sell or Hold?
        Engene Holdings Inc. has a consensus rating of Moderate Buy which is based on 3 buy ratings, 8 hold ratings and 0 sell ratings.
          What is Engene Holdings Inc.’s price target?
          The average price target for Engene Holdings Inc. is 6.86. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $28.00 ,the lowest forecast is $2.00. The average price target represents -15.03% Decrease from the current price of $8.07.
            What do analysts say about Engene Holdings Inc.?
            Engene Holdings Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of ENGN?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.